VIVO लाइव सिग्नल्स | Getagraph.com के साथ लाभ को अधिकतम करें

Live Chart Being Loaded With Signals

Commentary (31 Jan 2023 @ 02:30):

Stats
आज की मात्रा	5.63M
औसत मात्रा	686 607
बाजार मूल्य	1.49B
EPS	$-0.680 ( Q1 \| 2023-02-09 )
Last Dividend	$0.125 ( 2019-02-01 )
Next Dividend	$0 ( N/A )
P/E	21.09 (Sector) 42.63 (Industry) 0
ATR14	$0.299 (0.88%)

ACRS -0.90%

AKU -17.87%

APDN -0.73%

BDSX 2.00%

BIOC 0.00%

BNGO -7.69%

BNR 1.05%

CDNA 7.92%

CEMI 0.22%

CHEK -0.99%

CNTG -3.80%

CSTL 2.88%

DMTK -11.32%

DRIO 1.71%

EXAS -5.03%

FLDM -7.02%

FLGT -2.39%

GENE 1.35%

GH -0.59%

GTH 0.12%

HTGM 0.00%

ICLR 0.08%

IDXX -1.37%

ILMN -1.95%

ISPC -1.87%

LAB 0.00%

LMDX 0.00%

MDXH 0.84%

ME -7.58%

MEDP -2.94%

MYGN 0.62%

MYNZ -14.13%

NDRA -5.73%

NEO 3.97%

NEOG -2.07%

NOTV -4.05%

NTRA -1.56%

OCDX 0.92%

OLK 0.75%

OPGN 0.39%

OPK -0.79%

PMD 2.11%

PRPO 4.85%

PSNL -3.31%

RDNT 0.03%

SERA 3.50%

SHC -0.25%

SQL 0.00%

STIM -1.10%

STRR 2.71%

STRRP 8.67%

SYNH 0.02%

TRIB 2.90%

TTOO -1.66%

TWST 3.79%

VIVO 0.00%

XGN -1.62%

Insider Trading

Date	Person	Action	Amount	type
2023-01-31	Williams Felicia	Sell	10 274	Common Stock
2023-01-31	Williams Felicia	Sell	12 000	Stock Option (Right to Buy)
2023-01-31	Williams Felicia	Sell	8 740	Stock Option (Right to Buy)
2023-01-31	Williams Felicia	Sell	17 205	Stock Option (Right to Buy)
2023-01-31	Williams Felicia	Sell	5 796	Stock Option (Right to Buy)

INSIDER POWER
-88.56
Last 100 transactions
Buy: 118 571 \| Sell: 1 534 678

मात्रा सहसंबंध

लंबा: 0.42 (neutral)

छोटा: 0.51 (weak)

Signal:(71.236) Neutral

Meridian Bioscience Inc सहसंबंध

10 सबसे अधिक सकारात्मक सहसंबंध

10 सबसे अधिक नकारात्मक सहसंबंध

क्या आप जानते हैं?

कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।

कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।

Meridian Bioscience Inc सहसंबंध - मुद्रा/वस्त्र

-0.59
( weak negative )

-0.65
( weak negative )

-0.67
( moderate negative )

0.13
( neutral )

0.51
( weak )

-0.33
( neutral )

Meridian Bioscience Inc वित्तीय

Annual	2022
राजस्व:	$333.02M
सकल लाभ:	$188.36M (56.56 %)
EPS:	$0.960

FY	2022
राजस्व:	$333.02M
सकल लाभ:	$188.36M (56.56 %)
EPS:	$0.960

FY	2021
राजस्व:	$317.90M
सकल लाभ:	$201.15M (63.27 %)
EPS:	$1.650

FY	2020
राजस्व:	$253.67M
सकल लाभ:	$156.25M (61.60 %)
EPS:	$1.080

Financial Reports:

No articles found.

Meridian Bioscience Inc Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Meridian Bioscience Inc Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 0.950 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future

Information

First Dividend	$0.00678	1990-11-29
Last Dividend	$0.125	2019-02-01
Next Dividend	$0	N/A
Payout Date	2019-02-14
Next Payout Date	N/A
# dividends	114	--
Total Paid Out	$9.88	--
Avg. Dividend % Per Year	0.00%	--
Score	2.53	--
Div. Sustainability Score	0.950
Div.Growth Potential Score	0
Div. Directional Score	0.115	--

Next Divdend (Est)
(2024-07-17)

$0 Estimate 0.00 %

Dividend Stability

0.17 Bad

Dividend Score

2.53

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
1990	$0	0.00%
1991	$0	0.00%
1992	$0	0.00%
1993	$0	0.00%
1994	$0	0.00%
1995	$0	0.00%
1996	$0	0.00%
1997	$0	0.00%
1998	$0	0.00%
1999	$0	0.00%
2000	$0	0.00%
2001	$0	0.00%
2002	$0	0.00%
2003	$0.160	3.50%
2004	$0.178	3.83%
2005	$0.213	2.70%
2006	$0.307	2.09%
2007	$0.434	2.63%
2008	$0.560	1.88%
2009	$0.680	2.60%
2010	$0.760	3.51%
2011	$0.760	3.21%
2012	$0.950	4.98%
2013	$0.570	2.75%
2014	$0.800	3.06%
2015	$0.800	4.88%
2016	$0.800	4.10%
2017	$0.500	2.80%
2018	$0.500	3.47%
2019	$0.125	0.74%
2020	$0	0.00%
2021	$0	0.00%
2022	$0	0.00%
2023	$0	0.00%
2024	$0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Dividend History

Ex Date	Amount	Declaration Date	Record Date	Payment Date
01 Feb 2019	$0.125	24 Jan 2019	04 Feb 2019	14 Feb 2019
16 Nov 2018	$0.125	08 Nov 2018	19 Nov 2018	30 Nov 2018
09 Aug 2018	$0.125	31 Jul 2018	10 Aug 2018	20 Aug 2018
04 May 2018	$0.125	26 Apr 2018	07 May 2018	17 May 2018
02 Feb 2018	$0.125	25 Jan 2018	05 Feb 2018	15 Feb 2018
17 Nov 2017	$0.125	09 Nov 2017	20 Nov 2017	30 Nov 2017
03 Aug 2017	$0.125	27 Jul 2017	07 Aug 2017	17 Aug 2017
04 May 2017	$0.125	27 Apr 2017	08 May 2017	18 May 2017
02 Feb 2017	$0.125	25 Jan 2017	06 Feb 2017	16 Feb 2017
17 Nov 2016	$0.200	10 Nov 2016	21 Nov 2016	01 Dec 2016
04 Aug 2016	$0.200	28 Jul 2016	08 Aug 2016	18 Aug 2016
05 May 2016	$0.200	28 Apr 2016	09 May 2016	19 May 2016
04 Feb 2016	$0.200	27 Jan 2016	08 Feb 2016	18 Feb 2016
12 Nov 2015	$0.200	05 Nov 2015	16 Nov 2015	27 Nov 2015
30 Jul 2015	$0.200	23 Jul 2015	03 Aug 2015	13 Aug 2015
30 Apr 2015	$0.200	23 Apr 2015	04 May 2015	14 May 2015
29 Jan 2015	$0.200	22 Jan 2015	02 Feb 2015	13 Feb 2015
13 Nov 2014	$0.200	05 Nov 2014	17 Nov 2014	28 Nov 2014
31 Jul 2014	$0.200	22 Jul 2014	04 Aug 2014	14 Aug 2014
01 May 2014	$0.200	24 Apr 2014	05 May 2014	15 May 2014

Top 10 dividend Companies for NASDAQ

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
OXLC	Dividend Diamond	2024-09-16	Monthly	14	15.03%	9.60
DMLP	Dividend Diamond	2024-04-26	Quarterly	22	10.71%	9.35
OXSQ	Dividend Diamond	2024-09-16	Monthly	21	12.73%	9.02
ARLP	Dividend Royal	2024-05-07	Quarterly	26	9.67%	8.87
PNNT	Dividend Royal	2024-06-14	Monthly	18	9.49%	8.82
MFIC	Dividend Royal	2024-06-11	Quarterly	21	10.89%	8.79
SPOK	Dividend Royal	2024-05-23	Quarterly	20	8.73%	8.72
PSEC	Dividend Royal	2024-06-25	Monthly	21	9.03%	8.65
SBLK	Dividend Royal	2024-06-06	Quarterly	17	13.10%	8.63
GBDC	Dividend Royal	2024-11-29	Bi-Monthly	15	8.53%	8.62

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.197	1.500	-3.93	-5.90	[0 - 0.5]
returnOnAssetsTTM	-0.0528	1.200	-1.760	-2.11	[0 - 0.3]
returnOnEquityTTM	-0.0681	1.500	-1.867	-2.80	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	2.56	0.800	2.18	1.741	[1 - 3]
quickRatioTTM	1.472	0.800	6.05	4.84	[0.8 - 2.5]
cashRatioTTM	0.943	1.500	5.87	8.81	[0.2 - 2]
debtRatioTTM	0.0682	-1.500	8.86	-10.00	[0 - 0.6]
interestCoverageTTM	-65.48	1.000	-10.00	-10.00	[3 - 30]
operatingCashFlowPerShareTTM	-0.00825	2.00	-0.00275	-0.00550	[0 - 30]
freeCashFlowPerShareTTM	-0.148	2.00	-0.0740	-0.148	[0 - 20]
debtEquityRatioTTM	0.0914	-1.500	9.63	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.534	1.000	4.43	4.43	[0.2 - 0.8]
operatingProfitMarginTTM	-0.197	1.000	-5.93	-5.93	[0.1 - 0.6]
cashFlowToDebtRatioTTM	-0.0116	1.000	-1.176	-1.176	[0.2 - 2]
assetTurnoverTTM	0.268	0.800	-1.544	-1.235	[0.5 - 2]
Total Score				0.950

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-61.83	1.000	-6.35	0	[1 - 100]
returnOnEquityTTM	-0.0681	2.50	-1.200	-2.80	[0.1 - 1.5]
freeCashFlowPerShareTTM	-0.148	2.00	-0.0493	-0.148	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-0.00825	2.00	-0.00275	-0.00550	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	1.518	1.500	3.22	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	-0.00295	1.000	-2.57	0	[0.1 - 0.5]
Total Score				-0.720

Meridian Bioscience Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Meridian Bioscience Inc

Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, including real-time PCR amplification under the Revogene brand; isothermal DNA amplification under the Alethia brand; lateral flow immunoassay using fluorescent chemistry under the Curian brand; rapid immunoassay under the ImmunoCard and ImmunoCard STAT! brands; enzyme-linked immunoassays under the PREMIER brand; anodic stripping voltammetry under the LeadCare brands; and urea breath testing for H. pylori under the BreathID and BreathTek brand. This segment also offers respiratory illness assays, such as tests Group A strep, mycoplasma pneumonia, influenza, and pertussis; and blood chemistry products for LeadCare test kits for the detection of lead in blood. It sells products through direct sales force and independent distributors to acute care hospitals, reference laboratories, outpatient clinics, and physician office laboratories. The Life Science segment offers bulk antigens, antibodies, PCR/qPCR reagents, nucleotides, and bioresearch reagents used by in vitro diagnostic manufacturers, as well as researchers in immunological and molecular tests for human, animal, plant, and environmental applications. Meridian Bioscience, Inc. was incorporated in 1976 and is headquartered in Cincinnati, Ohio.